However, high expression of NLRP1 is associated with a decreased risk of death in PAAD (HR = 0.78, p = 1.7e−3), LUAD (HR = 0.80, p = 7.7e−3), and SKCM (HR = 0.90, p = 0.03). This evidence concerns the gene NLRP1 and pancreatic adenocarcinoma.